Details of the Drug

General Information of Drug (ID: DMLATOQ)

Drug Name

BAY1129980

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02134197) Dose-escalation Study of BAY1129980. U.S. National Institutes of Health.